News
TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics
1+ hour, 43+ min ago (190+ words) GLOBAL HEAD OF R&D Relfydess presentations include two encore post-hoc subgroup analyses of pooled phase III READY program data in moderate-to-severe frown lines and crow's feet. These data showed: Additionally, new Relfydess data includes results from an in vivo…...
Adimab Records Another Year of Double-Digit Clinical Program Growth
1+ day, 10+ hour ago (198+ words) " 11 New Clinical Programs in 2025 " 6 Partner Programs Have Reached the Market " 89 Total Clinical Programs Initiated to Date " Partners with new clinical programs in 2025 include Abogen, GSK, iTeos, Innovent, Invivyd, Kelonia Therapeutics, and Triveni Bio, among others. Adimab's latest partner program to…...
Allele Biotech to Partner with UC San Diego on ARPA-H Project to End Liver Transplant Shortage with 3D Bioprinting
1+ day, 10+ hour ago (500+ words) Allele Biotech to Partner with UC San Diego on ARPA-H Project to End Liver Transplant Shortage with 3D Bioprinting'BioSpace Allele Biotech to Partner with UC San Diego on ARPA-H Project to End Liver Transplant Shortage with 3D Bioprinting Allele will generate mRNA…...
Tahoe Therapeutics and Alloy Therapeutics to Form Joint Venture and Develop First-in-Class Antibody-Drug Conjugates for Hard-to-Treat Cancers
1+ day, 11+ hour ago (533+ words) Tahoe Therapeutics and Alloy Therapeutics to Form Joint Venture and Develop First-in-Class Antibody-Drug Conjugates for Hard-to-Treat Cancers'BioSpace Tahoe Therapeutics and Alloy Therapeutics to Form Joint Venture and Develop First-in-Class Antibody-Drug Conjugates for Hard-to-Treat Cancers The new company combines Tahoe's AI-powered…...
Proxima Raises $80 Million Led by DCVC to Power the Next Generation of Proximity-Based Medicines
1+ day, 20+ hour ago (517+ words) Proxima Raises $80 Million Led by DCVC to Power the Next Generation of Proximity-Based Medicines'BioSpace Proxima Raises $80 Million Led by DCVC to Power the Next Generation of Proximity-Based Medicines NEW YORK & BOSTON--(BUSINESS WIRE)--#AI--Proxima (formerly VantAI), the AI-native biotech…...
Nuclera Extends Series C Funding to $87M to Advance Antibody Engineering
1+ day, 20+ hour ago (571+ words) Nuclera Extends Series C Funding to $87M to Advance Antibody Engineering'BioSpace Nuclera Extends Series C Funding to $87M to Advance Antibody Engineering - Additional $12M financing led by Elevage Medical Technologies and Jonathan Milner alongside existing investors British Business Bank, and GK Goh - The…...
Alamar Biosciences Announces Launch of NULISAqpcr™ AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research
2+ day, 4+ hour ago (432+ words) Alamar Biosciences Announces Launch of NULISAqpcr" AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research'BioSpace Alamar Biosciences Announces Launch of NULISAqpcr" AD 5-plex Assay, Advancing Blood Based Biomarker Detection in Alzheimer's Disease Research FREMONT, Calif., Jan. 12, 2026 /CNW…...
Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio
2+ day, 5+ hour ago (760+ words) Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio'BioSpace Dyno Therapeutics Launches Dyno-yp2, a Top-Performing TfR1-Mediated AAV Capsid, to Further Diversify CNS Delivery Portfolio - New Dyno-yp2 capsid achieves both exceptional brain transduction and significant…...
10x Genomics Launches Study to Advance Research in Blood-Based Diagnostics for Autoimmune Disease
2+ day, 5+ hour ago (191+ words) Study aims to identify single cell immune signatures of disease activity and treatment response to support clinical care The study will be led by investigators Kevin Wei, MD, PhD, Jeffrey Sparks, MD, MMSc, Deepak Rao, MD, PhD, Paul Hoover, MD,…...
Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production
2+ day, 20+ hour ago (685+ words) Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production'BioSpace Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production Asimov's LV…...